• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pp90rsk1通过Ser-167的磷酸化调节雌激素受体介导的转录。

pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.

作者信息

Joel P B, Smith J, Sturgill T W, Fisher T L, Blenis J, Lannigan D A

机构信息

Center for Cell Signaling and Department of Pharmacology, University of Virginia, Charlottesville 22908, USA.

出版信息

Mol Cell Biol. 1998 Apr;18(4):1978-84. doi: 10.1128/MCB.18.4.1978.

DOI:10.1128/MCB.18.4.1978
PMID:9528769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC121427/
Abstract

The estrogen receptor alpha (ER), a member of the steroid receptor superfamily, contains an N-terminal hormone-independent transcriptional activation function (AF-1) and a C-terminal hormone-dependent transcriptional activation function (AF-2). Here, we used in-gel kinase assays to determine that pp90rsk1 activated by either epidermal growth factor (EGF) or phorbol myristate acetate specifically phosphorylates Ser-167 within AF-1. In vitro kinase assays demonstrated that pp90rsk1 phosphorylates the N terminus of the wild-type ER but not of a mutant ER in which Ser-167 was replaced by Ala. In vivo, EGF stimulated phosphorylation of Ser-167 as well as Ser-118. Ectopic expression of active pp90rsk1 increased the level of phosphorylation of Ser-167 compared to that of either a mutant pp90rsk1, which is catalytically inactive in the N-terminal kinase domain, or to that of vector control. The ER formed a stable complex with the mutant pp90rsk1 in vivo. Transfection of the mutant pp90rsk1 depressed ER-dependent transcription of both a wild-type ER and a mutant ER that had a defective AF-2 domain (ER TAF-1). Furthermore, replacing either Ser-118 or Ser-167 with Ala in ER TAF-1 showed similar decreases in transcription levels. A double mutant in which both Ser-118 and Ser-167 were replaced with Ala demonstrated a further decrease in transcription compared to either of the single mutations. Taken together, our results strongly suggest that pp90rsk1 phosphorylates Ser-167 of the human ER in vivo and that Ser-167 aids in regulating the transcriptional activity of AF-1 in the ER.

摘要

雌激素受体α(ER)是类固醇受体超家族的成员,包含一个N端激素非依赖性转录激活功能(AF-1)和一个C端激素依赖性转录激活功能(AF-2)。在此,我们使用凝胶内激酶分析来确定由表皮生长因子(EGF)或佛波酯肉豆蔻酸酯激活的pp90rsk1特异性磷酸化AF-1内的Ser-167。体外激酶分析表明,pp90rsk1磷酸化野生型ER的N端,但不磷酸化Ser-167被丙氨酸取代的突变型ER的N端。在体内,EGF刺激Ser-167以及Ser-118的磷酸化。与在N端激酶结构域无催化活性的突变型pp90rsk1或载体对照相比,活性pp90rsk1的异位表达增加了Ser-167的磷酸化水平。ER在体内与突变型pp90rsk1形成稳定复合物。突变型pp90rsk1的转染抑制了野生型ER和具有缺陷AF-2结构域的突变型ER(ER TAF-1)的ER依赖性转录。此外,在ER TAF-1中将Ser-118或Ser-167替换为丙氨酸显示转录水平有类似下降。与任何一个单突变相比,Ser-118和Ser-167都被替换为丙氨酸的双突变体显示转录进一步下降。综上所述,我们的结果强烈表明,pp90rsk1在体内磷酸化人ER的Ser-167,并且Ser-167有助于调节ER中AF-1的转录活性。

相似文献

1
pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.pp90rsk1通过Ser-167的磷酸化调节雌激素受体介导的转录。
Mol Cell Biol. 1998 Apr;18(4):1978-84. doi: 10.1128/MCB.18.4.1978.
2
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.表皮生长因子对未结合配体的雌激素受体的激活涉及丝裂原活化蛋白激酶途径和直接磷酸化作用。
EMBO J. 1996 May 1;15(9):2174-83.
3
Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.通过激活功能AF-1的磷酸化实现SRC-1与雌激素受体β的非配体依赖性募集。
Mol Cell. 1999 Apr;3(4):513-9. doi: 10.1016/s1097-2765(00)80479-7.
4
Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.雌二醇和蛋白激酶激活剂对雌激素受体介导转录的协同激活作用。
Mol Endocrinol. 1993 Mar;7(3):441-52. doi: 10.1210/mend.7.3.7683375.
5
A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.Akt在介导表皮生长因子和胰岛素样生长因子I的雌激素功能中所起的作用。
Endocrinology. 2000 Dec;141(12):4503-11. doi: 10.1210/endo.141.12.7836.
6
Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.核激素受体共激活因子对雌激素受体转录增强作用的分析
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10069-73. doi: 10.1073/pnas.93.19.10069.
7
Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.肽生长因子与雌激素受体的相互作用需要A/B结构域,且其发生独立于蛋白激酶C或雌二醇。
Endocrinology. 1996 May;137(5):1735-44. doi: 10.1210/endo.137.5.8612509.
8
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.磷脂酰肌醇3激酶/蛋白激酶B介导的雌激素受体α激活:抗雌激素耐药的新模型
J Biol Chem. 2001 Mar 30;276(13):9817-24. doi: 10.1074/jbc.M010840200. Epub 2001 Jan 3.
9
Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.作为人雌激素受体α激活功能1特异性转录共激活因子的p68 RNA解旋酶的纯化与鉴定
Mol Cell Biol. 1999 Aug;19(8):5363-72. doi: 10.1128/MCB.19.8.5363.
10
The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor.酵母DNA修复和TFIIH调节因子MMS19的人类同源物是雌激素受体的AF-1特异性共激活因子。
J Biol Chem. 2001 Jun 29;276(26):23962-8. doi: 10.1074/jbc.M101041200. Epub 2001 Mar 28.

引用本文的文献

1
TMEM97/Sigma 2 Receptor Increases Estrogen Receptor α Activity in Promoting Breast Cancer Cell Growth.跨膜蛋白97/西格玛2受体在促进乳腺癌细胞生长过程中增强雌激素受体α活性。
Cancers (Basel). 2023 Dec 2;15(23):5691. doi: 10.3390/cancers15235691.
2
RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer.RSK1和RSK2丝氨酸/苏氨酸激酶在癌症中调控不同的转录程序。
Front Cell Dev Biol. 2023 Jan 4;10:1015665. doi: 10.3389/fcell.2022.1015665. eCollection 2022.
3
p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors.p90核糖体S6激酶通过MDM2磷酸化调控甲状腺肿瘤中的p53信号通路。
Cancers (Basel). 2022 Dec 25;15(1):121. doi: 10.3390/cancers15010121.
4
Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways.神经调节素通过对多种信号通路的协同作用调节乳腺癌中的激素受体水平。
Clin Sci (Lond). 2023 Jan 13;137(1):1-15. doi: 10.1042/CS20220472.
5
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.乳腺癌中的雌激素受体 alpha 和 ESR1 突变。
Adv Exp Med Biol. 2022;1390:171-194. doi: 10.1007/978-3-031-11836-4_10.
6
Identifying requirements for RSK2 specific inhibitors.鉴定 RSK2 特异性抑制剂的需求。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1798-1809. doi: 10.1080/14756366.2021.1957862.
7
RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha.RSK2 通过抑制 ERK1/2 介导的雌激素受体 α 降解来维持成年期雌激素的稳态。
Cell Rep. 2020 Jul 21;32(3):107931. doi: 10.1016/j.celrep.2020.107931.
8
Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy.雌激素受体与妊娠期间雌激素诱导的子宫血管舒张。
Int J Mol Sci. 2020 Jun 18;21(12):4349. doi: 10.3390/ijms21124349.
9
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.长链非编码 RNA MIR2052HG 通过招募 EGR1 来调节 LMTK3 从而调控 ERα 水平和芳香酶抑制剂耐药性。
Breast Cancer Res. 2019 Apr 3;21(1):47. doi: 10.1186/s13058-019-1130-3.
10
Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.雌激素与乳腺癌:肥胖相关发展、生长和进展涉及的机制。
J Steroid Biochem Mol Biol. 2019 May;189:161-170. doi: 10.1016/j.jsbmb.2019.03.002. Epub 2019 Mar 6.

本文引用的文献

1
Site-directed mutagenesis by double polymerase chain reaction : megaprimer method.通过双聚合酶链反应进行定点诱变:大引物法
Methods Mol Biol. 1993;15:277-86. doi: 10.1385/0-89603-244-2:277.
2
Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation.丝裂原活化蛋白激酶的激活对于3T3-L1脂肪细胞分化并非必需,但会对其产生拮抗作用。
Mol Cell Biol. 1997 Oct;17(10):6068-75. doi: 10.1128/MCB.17.10.6068.
3
IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.核因子κB抑制蛋白α是丝裂原活化的90 kDa核糖体S6激酶的作用靶点。
EMBO J. 1997 Jun 2;16(11):3133-44. doi: 10.1093/emboj/16.11.3133.
4
Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria. Efficient synthesis of active protein kinases.细菌中丝裂原活化蛋白激酶磷酸化级联反应的重构。活性蛋白激酶的高效合成。
J Biol Chem. 1997 Apr 25;272(17):11057-62. doi: 10.1074/jbc.272.17.11057.
5
Steroid hormone receptors and their regulation by phosphorylation.类固醇激素受体及其磷酸化调控
Biochem J. 1996 Nov 1;319 ( Pt 3)(Pt 3):657-67. doi: 10.1042/bj3190657.
6
Binding of site-directed monoclonal antibodies to an epitope located in the A/B region (amino acids 140-154) of human estrogen receptor-induced conformational changes in an epitope in the DNA-binding domain.
Steroids. 1996 Sep;61(9):549-56. doi: 10.1016/s0039-128x(96)00109-2.
7
Aromatase inhibitors: rationale for use following antiestrogen therapy.芳香化酶抑制剂:抗雌激素治疗后使用的理论依据。
Semin Oncol. 1996 Aug;23(4 Suppl 9):21-7.
8
CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.CREB结合蛋白与类固醇受体辅激活因子-1协同作用,增强类固醇受体依赖性转录。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8884-8. doi: 10.1073/pnas.93.17.8884.
9
The signal-dependent coactivator CBP is a nuclear target for pp90RSK.信号依赖型共激活因子CBP是pp90RSK的一个核靶点。
Cell. 1996 Aug 9;86(3):465-74. doi: 10.1016/s0092-8674(00)80119-1.
10
Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability.酪蛋白激酶II对纯化的雌二醇配体化雌激素受体的磷酸化作用增加了雌激素反应元件的结合,但未改变配体稳定性。
Biochem Biophys Res Commun. 1996 Jun 25;223(3):554-60. doi: 10.1006/bbrc.1996.0933.